Mixed infection with itraconazole-susceptible and-resistant strains of Aspergillus fumigatus: Diagnostic and therapeutic implications.

[1]  B. Zwaan,et al.  The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus , 2019, PLoS pathogens.

[2]  W. Melchers,et al.  Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Chowdhary,et al.  Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment. , 2017, The Journal of infectious diseases.

[4]  J. Meis,et al.  Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures. , 2015, The Journal of antimicrobial chemotherapy.

[5]  J. Meis,et al.  Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait. , 2014, Environmental research.

[6]  J. Meis,et al.  Simple, Low-Cost Molecular Assays for TR34/L98H Mutations in the cyp51A Gene for Rapid Detection of Triazole-Resistant Aspergillus fumigatus Isolates , 2014, Journal of Clinical Microbiology.

[7]  Suhail Ahmad,et al.  Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait , 2013, BMC Infectious Diseases.

[8]  Z. Khan,et al.  Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis. , 2010, Journal of medical microbiology.

[9]  N. Papon,et al.  Recent trends in the epidemiology, diagnosis, treatment, and mechanisms of resistance in clinical Aspergillus species: A general review with a special focus on the Middle Eastern and North African region. , 2019, Journal of infection and public health.

[10]  Suhail Ahmad,et al.  Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1-->3)-beta-D-glucan in clinical specimens. , 2007, Journal of medical microbiology.